Integration of in vitro biorelevant dissolution and in vivo bioequivalence study to in silico PBPK modelling of furosemide oral formulations to predict bioequivalence in dogs by PBBM approach
model (Ibarra et al., 2019; Lu et al., 2017). Further, the model predictions were validated with a bioequivalence study in healthy dogs (n=6). A previously reported furosemide PBPK model ... local products obtained in…

